109 related articles for article (PubMed ID: 20960869)
1. [GAT(galactosyltransferase associated with tumor)].
Yamashita H; Saito E; Aoki D
Nihon Rinsho; 2010 Jul; 68 Suppl 7():768-71. PubMed ID: 20960869
[No Abstract] [Full Text] [Related]
2. [GAT (galactosyltransferase associated with tumor)].
Nozawa S; Fukuchi T
Nihon Rinsho; 1999 Dec; 57 Suppl():549-52. PubMed ID: 10778188
[No Abstract] [Full Text] [Related]
3. [GAT (galactosyltransferase associated with tumor)].
Fukuchi T; Nozawa S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():726-9. PubMed ID: 16149624
[No Abstract] [Full Text] [Related]
4. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D
Gan To Kagaku Ryoho; 1993 Feb; 20(2):279-85. PubMed ID: 8434967
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis].
Nozawa S; Udagawa Y; Ito K; Nishimura H; Yakushiji M; Shiota M; Noda K; Yajima M; Ohkura H; Murae M
Gan To Kagaku Ryoho; 1994 Mar; 21(4):507-16. PubMed ID: 8129392
[TBL] [Abstract][Full Text] [Related]
6. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (first report)--preclinical study of GAT assay kit and clinical study of normal level].
Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D
Gan To Kagaku Ryoho; 1993 Feb; 20(2):271-7. PubMed ID: 8434966
[TBL] [Abstract][Full Text] [Related]
7. Galactosyltransferase associated with tumor in patients with ovarian cancer: factors involved in elevation of serum galactosyltransferase.
Saitoh E; Aoki D; Susumu N; Udagawa Y; Nozawa S
Int J Oncol; 2003 Aug; 23(2):303-10. PubMed ID: 12851678
[TBL] [Abstract][Full Text] [Related]
8. [Clinical usefulness of tumor markers for the diagnosis of ovarian cancer].
Ito K; Udagawa Y; Nozawa S
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1964-70. PubMed ID: 1417005
[TBL] [Abstract][Full Text] [Related]
9. [Galactosyltransferase isozyme II (GT-II) as a new tumor marker for ovarian cancers--especially for clear cell carcinoma].
Nozawa S; Kiguchi K; Yajima M; Udagawa Y; Sakuma T; Iizuka R; Narisawa S; Sakayori M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1341-7. PubMed ID: 2511259
[TBL] [Abstract][Full Text] [Related]
10. [Clinical applications of ovarian cancer biomarkers].
Kataoka F; Aoki D
Nihon Rinsho; 2012 Jun; 70 Suppl 4():543-8. PubMed ID: 23156306
[No Abstract] [Full Text] [Related]
11. [Applications of tumor markers to the screening of endometrial and ovarian cancers].
Nozawa S; Takamatsu K; Tsukazaki K; Udagawa Y
Nihon Rinsho; 1996 Jun; 54(6):1665-73. PubMed ID: 8691627
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of serum glycoprotein galactosyltransferase levels in different histological types of ovarian carcinoma.
Gauduchon P; Tillier C; Guyonnet C; Heron JF; Bar-Guilloux E; Le Talaer JY
Cancer Res; 1983 Sep; 43(9):4491-6. PubMed ID: 6409405
[TBL] [Abstract][Full Text] [Related]
13. [Blood serum galactosyltransferase in oncologic diseases].
Mikhaĭlov AD; Zhordaniia KI; Ivanov PK
Med Radiol (Mosk); 1989 Mar; 34(3):31-4. PubMed ID: 2494414
[TBL] [Abstract][Full Text] [Related]
14. Mouse monoclonal antibodies which recognize a human (beta 1-4)galactosyl-transferase associated with tumor in body fluids.
Uemura M; Sakaguchi T; Uejima T; Nozawa S; Narimatsu H
Cancer Res; 1992 Nov; 52(22):6153-7. PubMed ID: 1423258
[TBL] [Abstract][Full Text] [Related]
15. [Tumor markers for ovarian cancers].
Aoki D; Kataoka F; Susumu N; Nozawa S
Nihon Rinsho; 2004 Oct; 62 Suppl 10():496-502. PubMed ID: 15535295
[No Abstract] [Full Text] [Related]
16. Ovarian cancer and tumor markers: sialic acid, galactosyltransferase and CA-125.
Goldhirsch A; Berger E; Müller O; Maibach R; Misteli S; Buser K; Roesler H; Brunner K
Oncology; 1988; 45(4):281-6. PubMed ID: 3133621
[TBL] [Abstract][Full Text] [Related]
17. [The usefulness and limitation of sugar antigen in ovarian cancers--with special reference to a new tumor marker, CA54/61].
Nozawa S
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1147-51. PubMed ID: 2499263
[TBL] [Abstract][Full Text] [Related]
18. [Detection of CA 125 in the serum and tissue of patients with ovarian neoplasms].
Kristen P; Beier HJ; Kaesemann H; Caffier H
Gynakol Rundsch; 1989; 29 Suppl 2():358-60. PubMed ID: 2693257
[No Abstract] [Full Text] [Related]
19. Tissue polypeptide antigen, galactosyltransferase isoenzyme II and pancreatic oncofetal antigen serum determination: role in pancreatic cancer diagnosis.
Basso D; Fabris C; Panucci A; Del Favero G; Angonese C; Plebani M; Petrin P; Burlina A; Naccarato R
Int J Pancreatol; 1988; 3 Suppl 1():S95-100. PubMed ID: 3145303
[TBL] [Abstract][Full Text] [Related]
20. Combination of markers may prove useful in screening for ovarian CA.
Oncology (Williston Park); 1994 Jun; 8(6):79-80. PubMed ID: 8074986
[No Abstract] [Full Text] [Related]
[Next] [New Search]